期刊文献+

鞘氨醇代谢物——肿瘤治疗的新靶点 被引量:1

Metabolites of sphingolipids as targets for cancer therapy
原文传递
导出
摘要 神经鞘脂类是细胞膜的结构成分之一。其代谢产物如神经酰胺、鞘氨醇、1-磷酸鞘氨醇亦是具有生物活性的信号分子,可作为第一和(或)第二信使调控着细胞的生命活动,如细胞的增殖、存活、迁移、新生血管形成。鞘氨醇激酶1是调节神经酰胺、1-磷酸鞘氨醇平衡的限速酶。近年研究表明,神经酰胺、鞘氨醇激酶1、1-磷酸鞘氨醇可调控肿瘤细胞代谢的多个环节,由此提示神经鞘脂类代谢产物可作为肿瘤治疗的新靶点。 Sphingolipids are structural components of cellular membranes.Their metabolites,such as ceramide,sphingosine,and sphingosine 1-phosphate are important bioactive molecules,which act as the first or second messengers regulating various cellular activities,including proliferation,survival,migration and neovascularization in vitro and in vivo tumor models.Sphingosine kinases 1(SPK1) is a critical regulator of the balance between ceramide and S1P.Recent studies show that ceramide,SPK1 and S1P can regulate many of the hallmarks of cancer. These studies suggest that these metabolites can serve as novel targets for cancer therapy.
出处 《军事医学科学院院刊》 CSCD 北大核心 2009年第6期593-595,共3页 Bulletin of the Academy of Military Medical Sciences
关键词 神经酰胺类 鞘氨醇激酶-1 1-磷酸鞘氨醇 抗肿瘤药 ceramides sphingosine kinase type 1 sphingosine 1-phosphate antineoplastic agents
  • 相关文献

参考文献15

  • 1Okazaki T, Bell RM, Hannun YA. Sphingomyelin turnover induced by vitamin D3 in HL-60 cells: role in cell differentiation [J]. J Biol Chem,1989,264(32) :19076 -19080.
  • 2Spiegel S, Merrill AH. Sphingolipid metabolism and cell growth regulation[J]. FASEB J, 1996,10(12) :1388 - 1397.
  • 3Ruvolo PP. Intracellular signal transduction pathways activated by ceramide and its metabolites[J]. Pharmcol Res, 2003, 47 (5) : 383 -392.
  • 4Ruvolo PP, Clark W, Mumby M, et al. A functional role for the B56 alpha-subunit of protein phosphatase 2A in ceramide-mediated regulation of BcL2 phosphorylation status and function [ J ]. J Biol Chem, 2002,277 (25) :22847 - 22852.
  • 5Modrak DE, Rodriguez MD, Goldenberg DM, et al. Sphingomyelin enhances chemotherapy efficacy and increases apoptosis in human colonic tumorxenografts[J]. Int J Oncol, 2002, 20(2) : 379 - 384.
  • 6Goulding CW, Giuliano AE, Cabot MC. SDZ PSC 833 ,the drug resistance modulator activates cellular ceramide formation by a pathway independent of P-glycoprotein [ J ]. Cancer Lett, 2000,149(1 -2):143 -151.
  • 7Sanchez T, Estrada-Hernandez T, Paik JH, et el. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability [J]. J Biol Chem, 2003, 278(47) :47281 -47290.
  • 8French KJ, Upson JJ, Keller SN ,et al. Antitumor activity of sphingosine kinase inhibitors [J]. J Pharmacol Exp Ther, 2006,318 (2) :596 -603.
  • 9Paugh SW, Paugh BS, Rahmani M, et al. A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia[J]. Blood,2008, 112(4) :1382 1391.
  • 10Yatomi Y, Ruan F, Hakomori S, et al. Sphingosine-1 -phosphate : a platelet-aetivating sphingolipid released from agonist-stimulated human platelets [ J ]. Blood, 1995,86 ( 1 ) : 193 - 202.

同被引文献15

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部